$MCADE presale is now live!

GE Healthcare is ‘well-positioned for above average profitability’

on Jan 4, 2023
Listen to this article
  • GE Healthcare debuted on Nasdaq under the ticker "GEHC" this morning.
  • William Blair's Nicholas Heymann shares his outlook on GE Healthcare.
  • Shares of General Electric Company are down about 20% on Wednesday.

General Electric Company (NYSE: GE) tanked 20% on Wednesday after it completed the spin-off of its healthcare unit.

Expert shares his outlook on GE Healthcare

GE Healthcare Technologies Inc debuted on Nasdaq this morning under the ticker “GEHC”. At writing, it has a market cap of over $25 billion.

Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.

For every three shares of General Electric, shareholders received one share of GE Healthcare Technologies, as part of the spin-off. Discussing the future of the new company, Nicholas Heymann – the Head of Global Industrial Infrastructure at William Blair said:

Very clearly people think that there’s upside at GE Healthcare. Today, large is not necessarily good. Complexity is hard to manage. Extensive diversity has been replaced by focus and agility. So, I do think that there is value to be unlocked here.

General Electric continues to own nearly 20% of GE Healthcare.

Heymann expects steady growth at GE Healthcare

In a statement, the multinational conglomerate also confirmed that it’s on track to separate GE Vernova and GE Aerospace in early 2024. Once all units are spun off as independent companies, the original General Electric will continue as an aviation-focused business.

GE Healthcare serves an estimated 1.0 billion patients every year and currently brings in about $18 billion in annual revenue. “Imaging” is its largest business with north of $9.0 billion in annual revenue. This morning on CNBC’s “Worldwide Exchange”, Heymann added:

GE Healthcare is one of two leaders in the diagnostic imaging space. It’s successfully rolled out artificial intelligence to help clinicians. So, I think this business is very well-positioned for steady growth with well above average profitability.